MSD counts advantages of Vaki acquisition
PHARMACEUTICAL company MSD last month announced the completion of its acquisition of Vaki, a specialist in fish monitoring equipment, from Pentair.
MSD, part of US based Merk, said the move will help it broaden its aquaculture portfolio, with Vaki’s precision farming and fish welfare solutions complementing its vaccine and pharmaceutical products.
Vaki will be a leading brand under the Biomark business within MSD Animal Health, focused on a range of equipment, products and technology for fish counting and size estimation.
Rick DeLuca, president, MSD Animal
Health, said: ‘Animal health intelligence and enhanced technology play an increasingly important role in animal health and care, providing access to real-time actionable data and insights to help, improve or enhance animal management and health outcomes.
‘We are excited to take this step forward with Vaki, as we add leading technology and services, which extend the
Rick DeLuca range of solutions in aquaculture we can provide to our customers.’
Biomark also announced the appointment of
Brian Beckley as its president. Beckley was chief operations officer of Biomark, responsible for commercial activities in support of the aquaculture and wildlife and conservation businesses, including the acquisition of Vaki.
Biomark specialises in electronic identification technology used in fisheries, wildlife and aquaculture research, including product sales, custom manufacturing, installation and extensive data management and analysis.